{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:52:38Z","timestamp":1772553158081,"version":"3.50.1"},"reference-count":17,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fund Nauka, Medical University \u201cParaskev Stoyanov\u201d Varna, Bulgaria","award":["22001"],"award-info":[{"award-number":["22001"]}]},{"name":"European Union\u2014NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria","award":["BG-RRP-2.004-0009-C02"],"award-info":[{"award-number":["BG-RRP-2.004-0009-C02"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Myelodysplastic syndromes (MDSs) are clonal hematopoietic disorders characterized by ineffective hematopoiesis and their diagnosis remains challenging, requiring integration of clinical, morphological, and genetic data. MicroRNAs (miRNAs) have emerged as potential biomarkers in MDS, offering insights into disease mechanisms and patient stratification. This study aimed to evaluate the diagnostic and prognostic significance of five plasma microRNAs (miR-22-3p, miR-144-3p, miR-16-5p, let-7a-5p, and miR-451a) in 40 patients with MDS, diagnosed according to WHO 2016 criteria and stratified by R-IPSS, and ten healthy controls. Plasma miRNA levels were measured by RT-qPCR. Expression profiles were compared between patients and controls, and further assessed in relation to disease subtypes, risk categories, and clinicopathological features. Expression analysis showed that miR-144-3p, miR-16-5p, let-7a-5p, and miR-451a were significantly lower in MDS patients compared to controls. MiR-451a demonstrated the highest diagnostic predictive value (p = 0.0022), followed by miR-16-5p (p = 0.0055), miR-144-3p (p = 0.0074), and let-7a-5p (p = 0.0092). Let-7a-5p was higher in MDS with excess blasts and both let-7a-5p and miR-451a were lower in the low-risk R-IPSS group. Strong correlations between miR-16-5p, miR-144-3p, and miR-451a were observed, probably reflecting their function in erythropoiesis. None of the investigated microRNAs showed independent prognostic significance for overall survival. In conclusion, circulating microRNAs, particularly miR-451a and let-7a-5p, show promise as supportive biomarkers that may complement existing diagnostic and risk assessment tools in MDS. Further studies are needed to validate their clinical applicability.<\/jats:p>","DOI":"10.3390\/ijms27052250","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:52:38Z","timestamp":1772207558000},"page":"2250","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Significance of Selected Plasma MicroRNAs in Myelodysplastic Syndromes"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8939-8972","authenticated-orcid":false,"given":"Svilena","family":"Atanasova","sequence":"first","affiliation":[{"name":"Hematology Clinic, University Hospital \u201cSt. Marina\u201d, Medical University, 9000 Varna, Bulgaria"},{"name":"Second Department of Internal Disease, ES Hematology, Medical University, 9000 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trifon","family":"Chervenkov","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Medical University, 9000 Varna, Bulgaria"},{"name":"Laboratory of Clinical Immunology, University Hospital \u201cSt. Marina\u201d, 9000 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Teneva","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Immunology, University Hospital \u201cSt. Marina\u201d, 9000 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stela","family":"Dimitrova","sequence":"additional","affiliation":[{"name":"Hematology Clinic, University Hospital \u201cSt. Marina\u201d, Medical University, 9000 Varna, Bulgaria"},{"name":"Second Department of Internal Disease, ES Hematology, Medical University, 9000 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilina","family":"Micheva","sequence":"additional","affiliation":[{"name":"Hematology Clinic, University Hospital \u201cSt. Marina\u201d, Medical University, 9000 Varna, Bulgaria"},{"name":"Second Department of Internal Disease, ES Hematology, Medical University, 9000 Varna, Bulgaria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/ejh.12735","article-title":"The role of microRNA in myelodysplastic syndromes: Beyond DNA methylation and histone modification","volume":"96","author":"Bulycheva","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.stem.2013.06.003","article-title":"The oncogenic microrna miR-22 targets the tet2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation","volume":"13","author":"Song","year":"2013","journal-title":"Cell Stem Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1080\/10428194.2020.1734591","article-title":"Increased expression of miR-22 corresponds to the high-risk subtypes of myelodysplastic syndromes and lower os rate","volume":"61","author":"Meng","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3324\/haematol.2017.177394","article-title":"miR-144\/451 represses the LKB1\/AMPK\/mTOR pathway to promote red cell precursor survival during recovery from acute anemia","volume":"103","author":"Fang","year":"2018","journal-title":"Haematologica"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1073\/pnas.0712312105","article-title":"A GATA-1-regulated microRNA locus essential for erythropoiesis","volume":"105","author":"Dore","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/modpathol.2014.108","article-title":"Plasma circulating-microrna profiles are useful for assessing prognosis in patients with cytogenetically normal myelodysplastic syndromes","volume":"28","author":"Zuo","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.7150\/jca.52455","article-title":"Reduced miR-16 levels are associated with vegf upregulation in high-risk myelodysplastic syndromes","volume":"12","author":"Xiong","year":"2021","journal-title":"J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1073\/pnas.0506654102","article-title":"Mir-15 and miR-16 induce apoptosis by targeting bcl2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.leukres.2012.11.011","article-title":"Expression analysis of mir-17-5p, mir-20a and let-7a micrornas and their target proteins in cd34+ bone marrow cells of patients with myelodysplastic syndromes","volume":"37","author":"Vasilatou","year":"2013","journal-title":"Leuk. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2011-01-330704","article-title":"Circulating micrornas let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndrome","volume":"118","author":"Zuo","year":"2011","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pigati, L., Yaddanapudi, S.C.S., Iyengar, R., Kim, D.-J., Hearn, S.A., Danforth, D., Hastings, M.L., and Duelli, D.M. (2010). Selective release of microrna species from normal and malignant mammary epithelial cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0013515"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4149\/neo_2017_411","article-title":"Microarray profiling defines circulating micrornas associated with myelodysplastic syndromes","volume":"64","author":"Merkerova","year":"2017","journal-title":"Neoplasma"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Vizirianakis, I.S., Papagiannopoulos, C.I., and Theodoroula, N.F. (2021). miR-16-5p promotes erythroid maturation of erythroleukemia cells by regulating ribosome biogenesis. Pharmaceuticals, 14.","DOI":"10.3390\/ph14020137"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1158\/0008-5472.CAN-10-2475","article-title":"Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21","volume":"71","author":"Tsuchiya","year":"2011","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2020.09.012","article-title":"Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through glut12-mediated warburg effect","volume":"495","author":"Shi","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Morais, M., Dias, F., Nogueira, I., Le\u00e3o, A., Gon\u00e7alves, N., Ara\u00fajo, L., Granja, S., Baltazar, F., Teixeira, A.L., and Medeiros, R. (2021). Cancer cells\u2019 metabolism dynamics in renal cell carcinoma patients\u2019 outcome: Influence of glut-1-related hsa-miR-144 and hsa-mir-186. Cancers, 13.","DOI":"10.3390\/cancers13071733"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method","volume":"25","author":"Schmittgen","year":"2001","journal-title":"Methods"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2250\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:50:09Z","timestamp":1772542209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27052250"],"URL":"https:\/\/doi.org\/10.3390\/ijms27052250","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]}}}